{"id":"https://openalex.org/W4362535366","doi":"https://doi.org/10.1158/1535-7163.22508893","title":"Supplementary Tables and Figures. from Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures","display_name":"Supplementary Tables and Figures. from Cetuximab Resistance in Squamous Carcinomas of the Upper Aerodigestive Tract Is Driven by Receptor Tyrosine Kinase Plasticity: Potential for mAb Mixtures","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362535366","doi":"https://doi.org/10.1158/1535-7163.22508893"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22508893","doi":"https://doi.org/10.1158/1535-7163.22508893","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508893","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22508893","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040889498","display_name":"Ida Kj\u00e6r","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ida Kj\u00e6r","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068897967","display_name":"Trine Lindsted","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Trine Lindsted","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018560912","display_name":"Camilla Fr\u00f6hlich","orcid":"https://orcid.org/0000-0001-8391-2416","observed_orcids":["https://orcid.org/0000-0001-8391-2416"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camilla Fr\u00f6hlich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046276741","display_name":"Jesper V. Olsen","orcid":"https://orcid.org/0000-0002-4747-4938","observed_orcids":["https://orcid.org/0000-0002-4747-4938"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jesper Velgaard Olsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062966348","display_name":"Ivan David Horak","orcid":"https://orcid.org/0009-0003-8726-4016","observed_orcids":["https://orcid.org/0009-0003-8726-4016"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivan David Horak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111779564","display_name":"Michael Kragh","orcid":"https://orcid.org/0000-0002-8360-3514","observed_orcids":["https://orcid.org/0000-0002-8360-3514"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Kragh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051105658","display_name":"Mikkel Wandahl Pedersen","orcid":"https://orcid.org/0000-0001-5711-9051","observed_orcids":["https://orcid.org/0000-0001-5711-9051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mikkel Wandahl Pedersen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.027899999171495438,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab-resistance","display_name":"cetuximab resistance","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.7519999742507935},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/upper-aerodigestive-tract","display_name":"upper aerodigestive tract","score":0.9879999756813049},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.9089999794960022},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr-knockdown","display_name":"EGFR knockdown","score":0.5350000262260437},{"id":"https://openalex.org/keywords/fadu-cell-line","display_name":"FaDu cell line","score":0.9729999899864197},{"id":"https://openalex.org/keywords/egfr-amplification","display_name":"EGFR amplification","score":0.6259999871253967},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9645673036575317},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5502713322639465},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.47282373905181885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.290386438369751},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.22155523300170898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.216615229845047},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20133650302886963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17139258980751038},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08131828904151917},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0791063904762268}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22508893","doi":"https://doi.org/10.1158/1535-7163.22508893","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508893","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22508893.v1","doi":"https://doi.org/10.1158/1535-7163.22508893.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508893.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22508893","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_and_Figures_from_Cetuximab_Resistance_in_Squamous_Carcinomas_of_the_Upper_Aerodigestive_Tract_Is_Driven_by_Receptor_Tyrosine_Kinase_Plasticity_Potential_for_mAb_Mixtures/22508893","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22508893","doi":"https://doi.org/10.1158/1535-7163.22508893","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508893","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2382343299","https://openalex.org/W4392688743","https://openalex.org/W2002967958","https://openalex.org/W2566975754","https://openalex.org/W2330599506","https://openalex.org/W2004439203","https://openalex.org/W4206287336","https://openalex.org/W2042327295","https://openalex.org/W2265421862","https://openalex.org/W1494092082"],"abstract_inverted_index":{"Table":[0],"S1":[1,18],"contains":[2],"IC50":[3],"values":[4],"for":[5,66],"cetuximab":[6,20,28,43,93,109,120],"inhibition,":[7],"EGFR":[8,24,36,59,74,88],"mutation":[9],"and":[10,27,42,77,83,101,121],"amplification":[11],"status":[12],"of":[13,50,73,79,107,119,128],"tested":[14],"cell":[15,31,96,130],"lines.":[16,32,97,131],"Figure":[17,33,46,54,56,68,86,98,114],"shows":[19,35,58,70],"binding":[21],"to":[22],"surface":[23],"on":[25],"HN5":[26,30,40,81,84,112],"resistant":[29,44,94],"S2":[34],"levels":[37,89],"in":[38,53,90,111,125],"parental":[39],"cells":[41],"clones.":[45],"S3":[47],"Overexposed":[48],"image":[49],"immunoblot":[51],"presented":[52],"2B.":[55],"S4":[57],"degradation":[60],"upon":[61],"treatment":[62],"with":[63],"anti-EGFR":[64],"2mixture":[65],"48h.":[67],"S5":[69],"LNA-mediated":[71],"knockdown":[72],"inhibit":[75],"growth":[76],"proliferation":[78],"HN5,":[80],"CR2,":[82],"CR14.":[85,113],"S6":[87],"FaDu":[91,95],"versus":[92],"S7":[99],"HER3":[100],"IGF1R":[102],"plasticity":[103],"as":[104],"a":[105,126],"mechanism":[106],"acquired":[108],"resistance":[110],"S8":[115],"Full":[116],"dose-response":[117],"curves":[118],"EGFR+HER3+IGF1R":[122],"5":[123],"mixture":[124],"panel":[127],"SCCUAT":[129]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-06T00:00:00"}